Sarepta Therapeutics
Price & Volume
Stats
See more52W Range | $10.41-$138.81 |
Market Cap | $1.8B |
Shares Short | 17M |
Financials
See moreRevenue (12 Mos) | $2.4B |
Revenue Growth (YoY) | -14.5% |
Gross Profit (12 Mos) | $443.8M |
Diluted EPS | -$2.83 |
News
See moreYahoo Finance • 10 days ago
Sarepta gene therapy Elevidys gets FDA Boxed Warning following two patient deaths
Yahoo Finance • 10 days ago
Sector Update: Health Care Stocks Ease Late Afternoon
Yahoo Finance • 20 days ago
The Bull Case For Sarepta Therapeutics (SRPT) Could Change Following ESSENCE Trial Miss and FDA Discussions
Yahoo Finance • 20 days ago
Sarepta Loses A Third Of Its Value On Failed Tests, Gene Therapy Outlook
About
CEO | Mr. Douglas S. Ingram Esq., J.D. |
CFO | Ryan H. Wong |
Address | 215 First Street, Cambridge, MA, United States, 02142 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 1,372 |
